NS
ADPT icon

NBC Securities’s Adaptive Biotechnologies ADPT Stock Holding History

NBC Securities’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$162K Buy
7,534
+54
+0.7% +$827 0.01% 925
2026
Q1 		$104K Sell
7,480
-17,192
-70% -$274K 0.01% 1081
2025
Q4 		$401K Buy
24,672
+7,910
+47% +$129K 0.03% 581
2025
Q3 		$251K Buy
16,762
+15,777
+1,602% +$192K 0.02% 749
2025
Q2 		$11K Buy
+985
New +$8.95K ﹤0.01% 1910

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

NBC Securities's ADPT Position: Q2 2026 in Review

NBC Securities increased its Adaptive Biotechnologies (ADPT) stake by 0.72% in Q2 2026, buying an estimated $827 and bringing the position to 7,534 shares worth $162K. The position accounts for 0.01% of the portfolio, ranked #925.

NBC Securities first reported a position in ADPT in Q2 2025 and has held it in 5 quarters since. The position peaked at $401K in Q4 2025. 301 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • NBC Securities held 7,534 shares of Adaptive Biotechnologies worth $162K as of Q2 2026.
  • NBC Securities bought 54 Adaptive Biotechnologies shares in Q2 2026, an estimated $827.
  • Adaptive Biotechnologies made up 0.01% of NBC Securities's portfolio in Q2 2026, its #925 holding.
  • NBC Securities first reported a position in Adaptive Biotechnologies in Q2 2025 and has held it in 5 quarters since.
  • NBC Securities's Adaptive Biotechnologies position peaked at $401K in Q4 2025.
  • 301 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.